Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Interest Expenses (2019 - 2025)

Neurogene's Interest Expenses history spans 5 years, with the latest figure at $1000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 99.76% year-over-year to $1000.0; the TTM value through Dec 2025 reached $197000.0, down 53.54%, while the annual FY2025 figure was $5000.0, 99.68% down from the prior year.
  • Interest Expenses reached $1000.0 in Q4 2025 per NGNE's latest filing, down from $42000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $414000.0 in Q4 2024 to a low of $1000.0 in Q4 2023.
  • Average Interest Expenses over 3 years is $52666.7, with a median of $3500.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: skyrocketed 41300.0% in 2024, then plummeted 99.76% in 2025.
  • A 3-year view of Interest Expenses shows it stood at $1000.0 in 2023, then surged by 41300.0% to $414000.0 in 2024, then tumbled by 99.76% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Interest Expenses are $1000.0 (Q4 2025), $42000.0 (Q3 2025), and $74000.0 (Q2 2025).